Moderna, Inc. — Director's Dealing 2020

Dec 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-12-07

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-07	Common Stock	M	1467	$12.21	Acquired	1467	Direct
2020-12-07	Common Stock	M	5000	$14.22	Acquired	6467	Direct
2020-12-07	Common Stock	M	3533	$12.21	Acquired	10000	Direct
2020-12-07	Common Stock	M	10000	$19.15	Acquired	20000	Direct
2020-12-07	Common Stock	S	1696	$153.86	Disposed	18304	Direct
2020-12-07	Common Stock	S	2459	$154.73	Disposed	15845	Direct
2020-12-07	Common Stock	S	789	$155.50	Disposed	15056	Direct
2020-12-07	Common Stock	S	1597	$156.95	Disposed	13459	Direct
2020-12-07	Common Stock	S	4863	$158.07	Disposed	8596	Direct
2020-12-07	Common Stock	S	2344	$159.14	Disposed	6252	Direct
2020-12-07	Common Stock	S	528	$159.75	Disposed	5724	Direct
2020-12-07	Common Stock	S	2619	$161.65	Disposed	3105	Direct
2020-12-07	Common Stock	S	2962	$162.64	Disposed	143	Direct
2020-12-07	Common Stock	S	143	$163.49	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-07	Stock Option (Right to Buy)	$12.21	M	1467	Disposed	2027-02-23	Common Stock (1467)	Direct
2020-12-07	Stock Option (Right to Buy)	$14.22	M	5000	Disposed	2028-02-28	Common Stock (5000)	Direct
2020-12-07	Stock Option (Right to Buy)	$12.21	M	3533	Disposed	2027-10-03	Common Stock (3533)	Direct
2020-12-07	Stock Option (Right to Buy)	$19.15	M	10000	Disposed	2026-08-10	Common Stock (10000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.24 to $154.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.25 to $155.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.26 to $156.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.51 to $157.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.60 to $158.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.65 to $159.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.66 to $160.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.05 to $162.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.17 to $163.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.37 to $163.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F12: 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.

F13: 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.

F14: 229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years).

F15: This option is fully vested and exercisable.